PAICS as a diagnostic and prognostic biomarker in bladder cancer: bioinformatics and molecular dynamics insights

Discover Oncology · Published 2026-08-03 · DOI 10.1007/s12672-026-05673-y

Free full text

Authors (5)

Conglin Du, Yongan Li, Qian Wang, Jing Shen, Zhiliang Xia

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Du, C., Li, Y., Wang, Q., et al. (2026). PAICS as a diagnostic and prognostic biomarker in bladder cancer: bioinformatics and molecular dynamics insights. Discover Oncology. https://doi.org/10.1007/s12672-026-05673-y

Related articles

• Metabolic reprogramming signature predicts immunotherapy efficacy in lung adenocarcinoma: Targeting SLC25A1 to overcome immune resistance · Chinese Journal of Cancer Research · 2025 · Cites or is cited by this article
• Molecular subtypes and prognostic signature rooted in disulfidptosis highlight tumor microenvironment in lung adenocarcinoma · Chinese Journal of Cancer Research · 2025 · Cites or is cited by this article
• cGAS-STING pathway-related genes as candidate molecules associated with cervical intraepithelial neoplasia: an exploratory bioinformatics analysis · Discover Oncology · 2026 · Same journal
• Pan-cancer analysis and spatial validation in endometrial cancer reveal CD3D as a prognostic and immunological biomarker · Discover Oncology · 2026 · Same journal
• Systems biology approach to gene network analysis identifies therapeutic and diagnostic targets in colorectal cancer · Discover Oncology · 2026 · Same journal
• FXYD6 functions as a tumor suppressor in lung adenocarcinoma via the OIP5-AS1/miR-4735-3p/FXYD6 axis · Discover Oncology · 2026 · Same journal
• RBM15-mediated ASPM m6A modification facilitates osteosarcoma progression via IGF2BP3-dependent manner · Discover Oncology · 2026 · Same journal
• Differential expression of LYZ across pan-cancer and its prognostic value and immune microenvironment regulatory mechanisms in glioma · Discover Oncology · 2026 · Same journal
• Pan-cancer analysis identifies ODF2 as a dual prognostic and predictive biomarker for immunotherapy · Discover Oncology · 2026 · Same journal
• Ion homeostasis related gene signature characterizes the immune landscape and predicts prognosis in lung adenocarcinoma · Discover Oncology · 2026 · Same journal